Aurobindo Pharma has received USFDA approval for the drug Tramadol Hydrochloride extended-release tablets, which is used for treating pain for extended period in adults. The drug is bio similar to Ultram ER product of Valeant Intl. Tramadol Hydrochloride has a market of USD 56 million per year in USA. Now, the company can manufacture and market the production in USA from January 2016.
Company Profile : Aurobindo Pharma Ltd
Leave a Reply